HomeBlog

On Friday, October 18, 2019 the Center for Medicinal Cannabis Research (CMCR) is hosting a one-day symposium celebrating the pioneers and exploring the progress, promise, and challenges of medicinal cannabis research. Click here for the agenda and further details.

 

The symposium is a free one-day event, but REGISTRATION IS REQUIRED.

 

To register, CLICK HERE

8:00 AM – 5:00 PM

Breakfast at 7:30 AM, lunch included

Location:  UC San Diego's Atkinson Hall, San Diego, California


 

Jared Aarons, ABC 10News San Diego, September 10, 2019

Starting this fall, the Pacific College of Oriental Medicine is offering the first-ever certificate program specializing in medical marijuana.

The three-semester class promises to teach health care professionals the basics of medical cannabis, so they can begin to use it in their practice.

"We thought it was important for health care professionals to have objective information about medical marijuana," says school President Jack Miller.

Miller says part of the program's purpose is to help dispel some of the myths surrounding medical marijuana.

Read the rest of the story here


Nick Musica, CBD Oil Review, August 21, 2019

Recently, Nick Musica of CBD Oil Review had the privilege of speaking with one of the most influential figures in cannabis research, Dr. Igor Grant. Dr. Grant is the Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California, San Diego, as well as a Distinguished Professor in the Department of Psychiatry.

Current CMCR studies are examining the effects of cannabis, and cannabidiol (CBD) specifically, on conditions like autism, psychosis, bipolar disorder, and pain, to name a few.

There is, quite possibly, no one who understands the benefits and effects of CBD better than Dr. Grant. Meet the researcher behind the research.

Read the article here


Scott LaFee, UC San Diego News Center, October 10, 2019

The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation’s oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.

The grant funding, to be allocated to five California-based research teams, will be used to study the efficacy and safety of medical cannabis as both a supplementary or alternative treatment for schizophrenia, rheumatoid arthritis, insomnia, alcohol dependence and anxiety linked to anorexia.

Read the article here


Robert Solomon, Healio, October 30, 2019

The full impact of legalizing medicinal cannabis in some parts of the U.S. is hindered by inaccurate, inconsistent information, according to a panelist at the OCTANe Medical Technology Innovation Forum.

Nearly three dozen states have legalized some form of medicinal cannabis. But those laws are not universal in their language, according to Governing.com, a website that covers politics, policy and management. In addition, cannabis is on the Drug Enforcement Administration’s Schedule I list — meaning it has no currently accepted medical use, high potential for abuse and risk for arrest with use.

Read the article here